MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ajmg.c.32031

Медицинская библиотека · American journal of medical genetics. Part C, Seminars in medical genetics · 2023

Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies.

Lekstrom-Himes Julie, Brooks P J, Koeberl Dwight D, Brower Amy, Goldenberg Aaron, Green Robert C, Morris Jill A, Orsini Joseph J, Yu Timothy W, Augustine Erika F

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

Most rare diseases are caused by single-gene mutations, and as such, lend themselves to a host of new gene-targeted therapies and technologies including antisense oligonucleotides, phosphomorpholinos, small interfering RNAs, and a variety of gene delivery and gene editing systems. Early successes are encouraging, however, given the substantial number of distinct rare diseases, the ability to scale these successes will be unsustainable without new development efficiencies. Herein, we discuss the need for genomic newborn screening to match pace with the growing development of targeted therapeutics and ability to rapidly develop individualized therapies for rare variants. We offer approaches to move beyond conventional "one disease at a time" preclinical and clinical drug development and discuss planned regulatory innovations that are necessary to speed therapy delivery to individuals in need. These proposals leverage the shared properties of platform classes of therapeutics and innovative trial designs including master and platform protocols to better serve patients and accelerate drug development. Ultimately, there are risks to these novel approaches; however, we believe that close partnership and transparency between health authorities, patients, researchers, and drug developers present the path forward to overcome these challenges and deliver on the promise of gene-targeted therapies for rare diseases.

Для цитирования: Lekstrom-Himes Julie, Brooks P J, Koeberl Dwight D, Brower Amy, Goldenberg Aaron, Green Robert C, Morris Jill A, Orsini Joseph J, Yu Timothy W, Augustine Erika F. Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies.. American journal of medical genetics. Part C, Seminars in medical genetics. 2023. DOI: 10.1002/ajmg.c.32031.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.